YGEN — Yourgene Health Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- £16.45m
- £31.98m
- £37.56m
Annual balance sheet for Yourgene Health, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.758 | 1.25 | 2.76 | 7 | 8.43 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.69 | 2.92 | 5.5 | 4.99 | 5.93 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 4.27 | 5.3 | 10 | 15.7 | 21.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.92 | 2.05 | 4.97 | 8.32 | 18.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 14.6 | 15.6 | 37.7 | 49.1 | 64.1 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.64 | 4.25 | 6.47 | 8.77 | 12.3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 17.2 | 4.9 | 11.4 | 16.2 | 31.3 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.6 | 10.7 | 26.3 | 32.9 | 32.7 |
| Total Liabilities & Shareholders' Equity | 14.6 | 15.6 | 37.7 | 49.1 | 64.1 |
| Total Common Shares Outstanding |